2021 annual financial data
Bionano Genomics 2021 Operating margin
Direct answer
Operating margin was -428.79%.
Operating income was -77,101,000 USD and net income was -72,435,000 USD.
Operating cash flow was -71,927,000 USD.
Get free Bionano Genomics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 17,981,000 USD
- Operating income
- -77,101,000 USD
- Net income
- -72,435,000 USD
- Operating cash flow
- -71,927,000 USD